| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Interest Income | 192,222 | 16.815% | 345,118 | 281,597 | 248,734 | 233,944 |
| Interest Expense | (19,984) | 7.969% | (39,260) | (31,036) | (25,182) | (22,963) |
| Net Interest Income | 172,238 | 17.936% | 305,858 | 250,561 | 223,552 | 210,981 |
| Other Operating Income | 5,620 | 6.198% | 8,895 | 9,629 | 4,959 | 10,094 |
| Total Operating Income | 177,858 | 17.526% | 314,753 | 260,190 | 228,511 | 221,075 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 177,858 | 17.526% | 314,753 | 260,190 | 228,511 | 221,075 |
| Operating Expenses | (64,201) | 15.573% | (126,989) | (108,800) | (106,014) | (101,486) |
| Impairment Losses on Loans & Advances | (52,450) | 19.433% | (82,965) | (77,364) | (55,757) | (37,672) |
| Other Impairment Losses | 0 | -- | 0 | 0 | 0 | 0 |
| Operating Profit / (Loss) | 61,207 | 18.003% | 104,799 | 74,026 | 66,740 | 81,917 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) before Taxation | 61,207 | 18.003% | 104,799 | 74,026 | 66,740 | 81,917 |
| Taxation | (10,105) | 32.282% | (17,420) | (10,272) | (15,174) | (14,052) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 51,102 | 15.537% | 87,379 | 63,754 | 51,566 | 67,865 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Depreciation & Amortisation | -- | -- | 12,017 | 13,448 | 12,304 | 14,624 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 10.220 | 15.480% | 17.480 | 12.750 | 13.420 | 18.100 |
| DPS (cts) | 5.100 | -- | 12.200 | 8.900 | 1.998 | -- |
| Dividend Payout Ratio (%) | 49.902% | -- | 69.794% | 69.804% | 14.888% | -- |
| Cash flow per share ($) | -- | -- | (0.131) | (0.420) | 0.019 | 0.451 |
| NBV per share ($) | 1.935 | -- | 1.911 | 1.835 | 1.762 | -- |
| Remarks: | Real time quote last updated: 24/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 51,102 |
| %Change | 15.537% |
| EPS / (LPS) | HKD 0.102 |
| NBV Per Share ($) | HKD 1.935 |